News
Ms. Grossman brings 25 years of accomplished finance and accounting experience in global, publicly-traded companies Company announces Ind ...
The global cancer supportive care products market is set to experience steady growth, with an estimated market value of USD 20.63 billion in 2022. According to industry forecasts, this market is ...
Aurobindo Pharma jumped 3.42% to Rs 1,119.55 after the pharma company said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban ...
Key stocks to watch on April 15 are shares of Swiggy, HCLTech, Dr Reddy, Tata Power, IREDA ICICI Lombard, ICICI Pru Life, among others, due to varied news developments and Q4 results.
Dr Reddy's has denied the workforce reduction claims. "We categorically deny the claim of a 25% workforce cost reduction and ...
Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...
Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to ...
Aurobindo Pharma said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg.
Aurobindo Pharma has received final USFDA approval to launch generic Rivaroxaban 2.5mg tablets in the US, targeting a $447 ...
5d
TipRanks on MSNAurobindo Pharma Secures USFDA Approval for Rivaroxaban TabletsAurobindo Pharma Ltd ( ($IN:AUROPHARMA) ) has issued an announcement. Aurobindo Pharma Limited has received final approval from the USFDA to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results